CA 15-3 and carcinoembryonic antigen in the clinical evaluation of breast cancer
- 30 August 1991
- journal article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 200 (2-3), 81-93
- https://doi.org/10.1016/0009-8981(91)90080-v
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Tumor marker kinetics in the monitoring of breast cancerCancer, 1990
- Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic diseaseCancer, 1989
- CA15-3: Its relationship to clinical stage and progression to metastatic disease in breast cancerBritish Journal of Surgery, 1989
- Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseasesBreast Cancer Research and Treatment, 1989
- Serum carcinoembryonic antigen in the diagnosis and prognosis of women with breast cancerEuropean Journal of Cancer and Clinical Oncology, 1984
- Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancerJAMA, 1983
- Tissue and plasma carcinoembryonic antigen in early breast cancer a prognostic factorCancer, 1983
- The Value of Serial Plasma Levels of Carcinoembryonic Antigen and Gross Cyst Disease Fluid Protein in Patients with Breast Carcinoma and Osseous MetastasesAnnals of Surgery, 1980
- Sequential Carcinoembryonic Antigen Levels in the Therapy of Metastatic Breast CancerAnnals of Internal Medicine, 1978
- Clinical correlation between CEA and breast cancerCancer, 1978